Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$11,602
in 1 filing
Open-market sales, last 90 days
$117,428
in 4 filings, $104K under 10b5-1 plans

Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 94 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-20 Chanda Sanjay Chief Development Officer Grant or award · Stock Option (right to buy) +77,000 77,000
2026-02-20 Marks Gilbert Lynn Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Readnour Robin Shane Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Wong Stephanie Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Martin Patricia A. Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Spigelman Melvin K Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Aziz Kabeer Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 FitzPatrick Margaret M Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-02-20 Zakrzewski Joseph S Director Grant or award · Stock Option (Right to Buy) +20,400 20,400
2026-01-12 Aziz Kabeer Director Grant or award +11,560 52,479
2026-01-12 Martin Patricia A. Director Grant or award +3,650 16,905
2026-01-12 Marks Gilbert Lynn Director Grant or award +11,560 75,309
2026-01-06 Day Lucy Chief Financial Officer Sale −5,512 $1.01 $6K 75,363
2026-01-06 Prior Stephen David Chief Strategy Officer Sale −2,858 $1.01 $3K 59,086
2026-01-06 Chanda Sanjay Chief Development Officer Sale −5,956 $1.01 $6K 75,823
2026-01-06 Eizen Joshua M See Remarks Sale −6,931 $1.01 $7K 152,499
2026-01-05 Day Lucy Chief Financial Officer Sale −3,295 $1.00 $3K 80,875
2026-01-05 Prior Stephen David Chief Strategy Officer Sale −3,604 $1.00 $4K 61,944
2026-01-05 Chanda Sanjay Chief Development Officer Sale −3,295 $1.00 $3K 81,779
2026-01-05 Eizen Joshua M See Remarks Sale −17,923 $1.00 $18K 159,430

Page 6 of 10 · 191 trades